Equivalent to CG-EDP3: Tetrapeptide-21 COA & Residual Solvent Limits for Serums
Molecular Weight & Diffusion Kinetics: Why 389.4 Da Tetrapeptide-21 Outperforms Larger Oligopeptides in Stratum Corneum Penetration
In the competitive landscape of anti-aging peptides, the molecular weight of an active ingredient is a critical determinant of its ability to reach the viable epidermis. Tetrapeptide-21 (CAS 960608-17-7), with a molecular weight of 389.4 Da, falls well below the 500 Da rule for efficient skin penetration. This low molecular weight, combined with its specific amino acid sequence (Gly-Glu-Lys-Gly), allows for passive diffusion through the lipid-rich stratum corneum, a feat that larger oligopeptides often struggle to achieve without chemical penetration enhancers. When evaluating a drop-in replacement for CG-EDP3, formulators must consider not just the peptide sequence but also the diffusion kinetics that this compact tetrapeptide offers. Our field experience shows that in comparative Franz cell diffusion studies, Tetrapeptide-21 demonstrates a steady-state flux that is consistent with its molecular size, making it a reliable performance benchmark for dermal delivery. Unlike larger peptides that may aggregate or require encapsulation, Tetrapeptide-21's inherent solubility and small size facilitate its incorporation into both aqueous and emulsion-based serums, ensuring consistent bioavailability. This is particularly relevant for R&D teams seeking a skin repair peptide that can stimulate collagen without the formulation complexity associated with higher molecular weight alternatives.
For a deeper dive into formulation stability, see our article on high-shear mixing stability of Tetrapeptide-21 as a Matrixyl 3000 alternative.
Residual Acetic Acid Control: Mitigating pH Drift and Stinging in Sensitive Skin Formulations with Tight Solvent Limits
One of the most overlooked aspects of peptide sourcing is the residual solvent profile, which can directly impact the safety and stability of the final cosmetic product. Tetrapeptide-21 is typically synthesized via solid-phase peptide synthesis (SPPS) and cleaved using trifluoroacetic acid (TFA), often followed by an ion-exchange step to replace TFA with acetate. Consequently, the final lyophilized powder may contain residual acetic acid. While acetic acid is generally recognized as safe, excessive levels can cause a significant pH drop in unbuffered serums, leading to potential skin irritation, stinging, and even destabilization of the formulation. As a global manufacturer of cosmetic peptides, NINGBO INNO PHARMCHEM CO.,LTD. implements rigorous purification protocols to control residual acetic acid to levels that prevent such issues. Our standard specification for Tetrapeptide-21 includes a limit for residual acetic acid, typically not exceeding 1.0%, as confirmed by ion chromatography. This tight control is essential for formulators developing products for sensitive skin or those aiming for a "no-sting" claim. In our field experience, we have observed that batches with acetic acid content above 1.5% can cause a pH drift of more than 0.5 units in a simple 1% peptide solution, which is unacceptable for most commercial serums. Therefore, procurement managers must verify the residual solvent limits on the Certificate of Analysis (COA) to ensure the peptide is suitable for their specific formulation matrix.
COA Comparison: Assay, Moisture, and Residual Solvent Specifications for CG-EDP3 Equivalent Tetrapeptide-21
When sourcing an equivalent to CG-EDP3, a detailed COA comparison is indispensable. Below is a technical comparison of typical specifications for Tetrapeptide-21 from NINGBO INNO PHARMCHEM CO.,LTD. versus generic market offerings. This table highlights the critical parameters that ensure a true drop-in replacement with consistent performance.
| Parameter | NINGBO INNO PHARMCHEM Specification | Typical Market Specification | Analytical Method |
|---|---|---|---|
| Appearance | White to off-white powder | White to off-white powder | Visual |
| Assay (HPLC) | ≥ 98.0% | ≥ 95.0% | HPLC |
| Moisture (Karl Fischer) | ≤ 5.0% | ≤ 8.0% | KF Titration |
| Residual Acetic Acid | ≤ 1.0% | ≤ 2.0% (often not reported) | Ion Chromatography |
| Residual TFA | ≤ 0.1% | ≤ 0.5% | Ion Chromatography |
| Peptide Content | ≥ 85.0% | Not always specified | Elemental Analysis |
| Heavy Metals | ≤ 10 ppm | ≤ 20 ppm | ICP-MS |
As shown, the tighter controls on assay, moisture, and residual solvents directly translate to higher purity and better formulation predictability. For instance, lower moisture content reduces the risk of hydrolysis during storage, while stringent residual TFA limits minimize potential skin sensitization. These are not just numbers on a page; they are the result of optimized synthesis and purification processes that ensure every batch of Tetrapeptide-21 meets the demands of high-end anti-aging peptide serums. For cold-process hydrogel applications, refer to our guide on preventing syneresis and viscosity collapse with Tetrapeptide-21.
Bulk Packaging & Stability: IBC and Drum Logistics for High-Purity Tetrapeptide-21 Supply Chains
For procurement managers, the logistics of receiving and storing bulk peptides are as critical as the chemical specifications. Tetrapeptide-21 is a hygroscopic powder that must be protected from moisture and oxygen to maintain its high purity over its shelf life. NINGBO INNO PHARMCHEM CO.,LTD. offers standard packaging in 1 kg, 5 kg, and 25 kg net weight per container, using food-grade HDPE drums with double-layer PE bag liners and nitrogen flushing. For larger orders, intermediate bulk containers (IBCs) can be arranged, though the typical order quantity for this cosmetic grade peptide is within drum-scale volumes. Each drum is sealed with a tamper-evident closure and labeled with the product name, CAS number, batch number, and net weight. From a stability standpoint, our accelerated testing at 40°C/75% RH for 6 months shows less than 2% degradation when stored in the original sealed packaging. However, once opened, the powder should be used promptly or stored under inert gas at -20°C. A non-standard parameter to consider is the potential for electrostatic charge buildup during dispensing in low-humidity environments, which can cause powder adhesion to surfaces and minor loss. Our field team recommends using anti-static equipment or maintaining a relative humidity of 40-50% in the handling area to mitigate this. This hands-on knowledge ensures that your receiving and formulation processes run smoothly, without unexpected material handling issues.
Frequently Asked Questions
How does the molecular weight of Tetrapeptide-21 affect skin penetration compared to CG-EDP3?
Both Tetrapeptide-21 and CG-EDP3 share the same amino acid sequence and thus the same molecular weight of 389.4 Da. This low molecular weight is ideal for passive diffusion through the stratum corneum, as molecules under 500 Da generally penetrate more efficiently. Therefore, the skin penetration profile of our Tetrapeptide-21 is equivalent to that of CG-EDP3, making it a true drop-in replacement.
What residual solvent limits should procurement verify on the COA for Tetrapeptide-21?
Procurement should verify limits for residual acetic acid (≤1.0%) and residual TFA (≤0.1%). These solvents are common byproducts of peptide synthesis and can affect formulation pH and skin compatibility. A reliable COA will also include moisture content (≤5.0%) and assay (≥98.0%) to ensure the peptide's stability and purity.
Is Tetrapeptide-21 from NINGBO INNO PHARMCHEM a direct equivalent to CG-EDP3?
Yes, our Tetrapeptide-21 is synthesized to be a direct equivalent to CG-EDP3, with identical amino acid sequence and high purity. It can be used as a seamless drop-in replacement in your existing formulations without the need for reformulation, provided the COA specifications align with your requirements.
What packaging options are available for bulk orders of Tetrapeptide-21?
We offer standard packaging in 1 kg, 5 kg, and 25 kg HDPE drums with nitrogen flushing to ensure product stability during transport and storage. For larger volumes, IBCs can be arranged upon request. All packaging is designed to protect the hygroscopic powder from moisture and oxygen.
How does residual acetic acid impact serum formulations?
Excessive residual acetic acid can lower the pH of the final serum, potentially causing skin irritation or stinging, especially in formulations for sensitive skin. By controlling residual acetic acid to ≤1.0%, our Tetrapeptide-21 minimizes pH drift and ensures a safer, more comfortable product for end-users.
Sourcing and Technical Support
When sourcing Tetrapeptide-21 as an equivalent to CG-EDP3, the combination of rigorous COA specifications, controlled residual solvents, and reliable bulk packaging ensures a smooth integration into your anti-aging serum line. Our technical team is ready to support your R&D and procurement needs with batch-specific documentation and formulation guidance. To request a batch-specific COA, SDS, or secure a bulk pricing quote, please contact our technical sales team.